Clinical Trials Logo

Skin Infection clinical trials

View clinical trials related to Skin Infection.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06149117 Completed - Clinical trials for Upper Respiratory Tract Infection

Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China

Start date: November 16, 2022
Phase: Phase 4
Study type: Interventional

Main research purpose To investigate the pharmacokinetics of the test preparation azithromycin capsule and the reference preparation azithromycin capsule (Sumamed®) in Chinese healthy adult subjects by single oral administration in fasting state, and to evaluate the bioequivalence of the two preparations by oral administration in fasting state. Secondary research purpose To investigate the safety of the test preparation azithromycin capsule and the reference preparation "Sumamed®" in healthy subjects.

NCT ID: NCT06087809 Completed - Clinical trials for Community-acquired Pneumonia

Improving Short Course Treatment for Common Pediatric Infections

Start date: February 15, 2023
Phase: N/A
Study type: Interventional

Randomized quality improvement trial to improve the proportion of cases of community-acquired pneumonia (CAP) treated with no more than 5 days of antibiotics the proportion of cases of skin and soft tissue infections (SSTI) treated with no more than 7 days of antibiotics by primary care clinicians (PCC) within the Pediatric Physicians' Organization at Children's (PPOC), a state-wide pediatric primary care network. Interventions include education and feedback; clinical decision support (CDS) delivered at the point of care; and the combination of the two.

NCT ID: NCT04239521 Completed - Asthma Clinical Trials

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

Start date: October 1, 2020
Phase:
Study type: Observational

This study series consists of four related studies and aims to explore and describe many important elements of alopecia areata over three key areas: (1) the current epidemiology of alopecia areata, (2) the prevalence and incidence of psychiatric co-morbidities in people with alopecia areata, (3) the prevalence and incidence of autoimmune and atopic conditions in people with alopecia areata, and (4) the incidence of common infections in people with alopecia areata.

NCT ID: NCT03929224 Completed - Skin Infection Clinical Trials

The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown

Start date: October 25, 2018
Phase: Phase 4
Study type: Interventional

Postoperative medicinal grade honey in post-operative care may prevent bone anchored hearing aid associated skin breakdown better than standard care of bacitracin ointment alone in adult patients.

NCT ID: NCT02512614 Completed - Fever Clinical Trials

Evaluation of Novel Antimicrobial Hand Towels

Start date: March 2012
Phase: Phase 2/Phase 3
Study type: Interventional

In March 2012, the investigators initiated a prospective, cluster-randomized, controlled field trial in Kisumu County, located in an area in western Kenya which has the highest under-five mortality rate in Kenya with 149 childhood deaths per 1,000 live births 9. The study was designed to evaluate the effectiveness of an antimicrobial hand towel (hereafter referred to as towel) in preventing diarrheal diseases, acute respiratory infections, self-reported fever, and skin infections in children <2 years old.

NCT ID: NCT02052388 Completed - Bacterial Infection Clinical Trials

Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

Start date: February 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of three different dosing regimens of brilacidin compared to daptomycin for the treatment of serious skin infections. This study will aid in selecting the appropriate dose of brilacidin for later stage studies.

NCT ID: NCT01593761 Completed - Skin Infection Clinical Trials

Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus

CG400549
Start date: June 2012
Phase: Phase 2
Study type: Interventional

Primary Objective: To make a preliminary assessment of the efficacy of CG400549 (960 mg daily) in subjects with cABSSSI (major cutaneous abscesses) due to MRSA. Secondary Objective(s): - To assess the pharmacokinetics of CG400549 (960 mg daily) in subjects with cABSSSI due to MRSA - To explore the in vitro susceptibility of cABSSSI-related bacteria to CG400549. - To assess the safety of multiple doses of CG400459

NCT ID: NCT00619710 Completed - Cellulitis Clinical Trials

Complicated Skin and Skin Structure Infections

Start date: February 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the non-inferiority of meropenem (Merrem) and imipenem in hospitalised subjects with complicated skin and skin structure infections.